Condition or disease |
---|
HBP |
Study Type : | Observational |
Estimated Enrollment : | 30 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | HBP Synchrony Using ECG Belt |
Actual Study Start Date : | June 1, 2021 |
Estimated Primary Completion Date : | March 1, 2022 |
Estimated Study Completion Date : | May 1, 2022 |
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
Exclusion Criteria:
●Patient is ventricular pacer dependent
United States, Florida | |
Orlando Cardiac & Vascular Specialists | Recruiting |
Altamonte Springs, Florida, United States, 32701 | |
Contact: Sambit Mondal, MD 407-915-5643 sambitmondal@gmail.com |
Tracking Information | |||
---|---|---|---|
First Submitted Date | June 11, 2021 | ||
First Posted Date | June 18, 2021 | ||
Last Update Posted Date | June 18, 2021 | ||
Actual Study Start Date | June 1, 2021 | ||
Estimated Primary Completion Date | March 1, 2022 (Final data collection date for primary outcome measure) | ||
Current Primary Outcome Measures |
Characterize the electrical dispersion using SDAT [ Time Frame: 1 year ] Characterize the electrical dispersion between intrinsic to both Selective HIS pacing and Non-Selective HIS pacing using Standard Deviation Activation Timing of the ECG Belt system.
|
||
Original Primary Outcome Measures | Same as current | ||
Change History | No Changes Posted | ||
Current Secondary Outcome Measures | Not Provided | ||
Original Secondary Outcome Measures | Not Provided | ||
Current Other Pre-specified Outcome Measures | Not Provided | ||
Original Other Pre-specified Outcome Measures | Not Provided | ||
Descriptive Information | |||
Brief Title | HIS Bundle Pacing Synchrony Comparing HIS Pacing to Intrinsic Conduction While Using the Medtronic ECG Belt System | ||
Official Title | HBP Synchrony Using ECG Belt | ||
Brief Summary | The HBP Synchrony Using ECG Belt study is a prospective, non-randomized single site physician-initiated research study. The study will collect ECG Belt data from up to 30 subjects at one single center. The target population will include subjects with a currently implanted Medtronic cardiac implantable device who have a HIS placed lead. The purpose of the study is to characterize the electrical dispersion using the ECG Belt provided by Medtronic in patients who have a HIS placed lead and understanding the amount of synchrony with intrinsic conduction compared to HIS pacing. | ||
Detailed Description | Not Provided | ||
Study Type | Observational | ||
Study Design | Observational Model: Cohort Time Perspective: Prospective |
||
Target Follow-Up Duration | Not Provided | ||
Biospecimen | Not Provided | ||
Sampling Method | Non-Probability Sample | ||
Study Population | The target population will include subjects with normal EF who have a Medtronic device and a HIS placed RV lead. In addition, we will include subjects who have intact AV conduction. | ||
Condition | HBP | ||
Intervention | Not Provided | ||
Study Groups/Cohorts | Not Provided | ||
Publications * | Not Provided | ||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||
Recruitment Information | |||
Recruitment Status | Recruiting | ||
Estimated Enrollment |
30 | ||
Original Estimated Enrollment | Same as current | ||
Estimated Study Completion Date | May 1, 2022 | ||
Estimated Primary Completion Date | March 1, 2022 (Final data collection date for primary outcome measure) | ||
Eligibility Criteria |
Inclusion Criteria:
Exclusion Criteria: ●Patient is ventricular pacer dependent |
||
Sex/Gender |
|
||
Ages | 18 Years and older (Adult, Older Adult) | ||
Accepts Healthy Volunteers | Not Provided | ||
Contacts | |||
Listed Location Countries | United States | ||
Removed Location Countries | |||
Administrative Information | |||
NCT Number | NCT04930601 | ||
Other Study ID Numbers | OSCMondal062021 | ||
Has Data Monitoring Committee | Not Provided | ||
U.S. FDA-regulated Product |
|
||
IPD Sharing Statement |
|
||
Responsible Party | SAMBIT MONDAL, Orlando Cardiac and Vascular Specialists | ||
Study Sponsor | SAMBIT MONDAL | ||
Collaborators | Not Provided | ||
Investigators | Not Provided | ||
PRS Account | Orlando Cardiac and Vascular Specialists | ||
Verification Date | June 2021 |